USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | 17.9 Million | 30.6 Million |
Net Income | - | - | - | - | -259.6 Million | -26.6 Million |
Depreciation & Amortization | - | - | - | - | 95.1 Million | 89.5 Million |
Deferred income taxes | - | - | - | - | -40.4 Million | -11.7 Million |
Stock-based compensation | - | - | - | - | 3 Million | 3.4 Million |
Change in working capital | - | - | - | - | 61.9 Million | -18.6 Million |
Other non-cash items | - | - | - | - | 157.9 Million | -5.4 Million |
Investing Cash Flow | - | - | - | - | -62.1 Million | -93.2 Million |
Investments in PPE | - | - | - | - | -73.4 Million | -93.5 Million |
Acquisitions | - | - | - | - | 2.2 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | -62.1 Million | - |
Financing Cash Flow | - | - | - | - | 79.8 Million | 3.7 Million |
Debt repayment | - | - | - | - | -11.9 Million | -177.9 Million |
Dividends payments | - | - | - | - | -1.4 Million | -2.7 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 93.1 Million | 184.3 Million |
Accounts receivables | - | - | - | - | 37.6 Million | -15.8 Million |
Accounts payables | - | - | - | - | -35.4 Million | 28.2 Million |
Inventory | - | - | - | - | 57.8 Million | -25 Million |
Other working capital | - | - | - | - | 3.8 Million | -6 Million |
Cash at beginning of period | - | - | - | - | 20.5 Million | 79.4 Million |
Cash at end of period | - | - | - | - | 56.1 Million | 20.5 Million |
Capital Expenditure | - | - | - | - | -73.4 Million | -93.5 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 35.6 Million | -58.9 Million |
Free Cash Flow | - | - | - | - | -55.5 Million | -62.9 Million |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2015 FY | 2015 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -259.6 Million | -56.4 Million |
Depreciation & Amortization | - | - | - | - | 95.1 Million | 24.7 Million |
Deferred income taxes | - | - | - | - | -40.4 Million | -4.4 Million |
Stock-based compensation | - | - | - | - | 3 Million | 700 Thousand |
Change in working capital | - | - | - | - | 61.9 Million | 11.8 Million |
Other non-cash items | - | - | - | - | 157.9 Million | 16.5 Million |
Investing Cash Flow | - | - | - | - | -62.1 Million | -14.8 Million |
Investments in PPE | - | - | - | - | -73.4 Million | -15.8 Million |
Acquisitions | - | - | - | - | 2.2 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | -62.1 Million | -14.8 Million |
Financing Cash Flow | - | - | - | - | 79.8 Million | 69.1 Million |
Debt repayment | - | - | - | - | -11.9 Million | -222.8 Million |
Dividends payments | - | - | - | - | -1.4 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 93.1 Million | -153.7 Million |
Accounts receivables | - | - | - | - | 37.6 Million | 27.3 Million |
Accounts payables | - | - | - | - | -35.4 Million | -26.4 Million |
Inventory | - | - | - | - | 57.8 Million | 26.3 Million |
Other working capital | - | - | - | - | 3.8 Million | -30.8 Million |
Cash at beginning of period | - | - | - | - | 20.5 Million | 8.9 Million |
Cash at end of period | - | - | - | - | 56.1 Million | 56.1 Million |
Capital Expenditure | - | - | - | - | -73.4 Million | -15.8 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 35.6 Million | 47.2 Million |
Free Cash Flow | - | - | - | - | -55.5 Million | -22.9 Million |
FGR
7110
4142
6858
000400
OXBOF